277 related articles for article (PubMed ID: 22449814)
1. Connecting mTORC1 signaling to SREBP-1 activation.
Bakan I; Laplante M
Curr Opin Lipidol; 2012 Jun; 23(3):226-234. PubMed ID: 22449814
[TBL] [Abstract][Full Text] [Related]
2. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway.
Peterson TR; Sengupta SS; Harris TE; Carmack AE; Kang SA; Balderas E; Guertin DA; Madden KL; Carpenter AE; Finck BN; Sabatini DM
Cell; 2011 Aug; 146(3):408-20. PubMed ID: 21816276
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP.
Ricoult SJ; Yecies JL; Ben-Sahra I; Manning BD
Oncogene; 2016 Mar; 35(10):1250-60. PubMed ID: 26028026
[TBL] [Abstract][Full Text] [Related]
4. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways.
Yecies JL; Zhang HH; Menon S; Liu S; Yecies D; Lipovsky AI; Gorgun C; Kwiatkowski DJ; Hotamisligil GS; Lee CH; Manning BD
Cell Metab; 2011 Jul; 14(1):21-32. PubMed ID: 21723501
[TBL] [Abstract][Full Text] [Related]
5. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M
Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
[TBL] [Abstract][Full Text] [Related]
6. DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease.
Chen H; Shen F; Sherban A; Nocon A; Li Y; Wang H; Xu MJ; Rui X; Han J; Jiang B; Lee D; Li N; Keyhani-Nejad F; Fan JG; Liu F; Kamat A; Musi N; Guarente L; Pacher P; Gao B; Zang M
Hepatology; 2018 Aug; 68(2):496-514. PubMed ID: 29457836
[TBL] [Abstract][Full Text] [Related]
7. Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway.
Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Wang G; Qiu Z
Food Funct; 2019 Jun; 10(6):3410-3420. PubMed ID: 31123744
[TBL] [Abstract][Full Text] [Related]
8. Insulin-induced de novo lipid synthesis occurs mainly via mTOR-dependent regulation of proteostasis of SREBP-1c.
Dong Q; Majumdar G; O'Meally RN; Cole RN; Elam MB; Raghow R
Mol Cell Biochem; 2020 Jan; 463(1-2):13-31. PubMed ID: 31541353
[TBL] [Abstract][Full Text] [Related]
9. mTORC1 Down-Regulates Cyclin-Dependent Kinase 8 (CDK8) and Cyclin C (CycC).
Feng D; Youn DY; Zhao X; Gao Y; Quinn WJ; Xiaoli AM; Sun Y; Birnbaum MJ; Pessin JE; Yang F
PLoS One; 2015; 10(6):e0126240. PubMed ID: 26042770
[TBL] [Abstract][Full Text] [Related]
10. Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase.
Owen JL; Zhang Y; Bae SH; Farooqi MS; Liang G; Hammer RE; Goldstein JL; Brown MS
Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16184-9. PubMed ID: 22927400
[TBL] [Abstract][Full Text] [Related]
11. Map4k4 suppresses Srebp-1 and adipocyte lipogenesis independent of JNK signaling.
Danai LV; Guilherme A; Guntur KV; Straubhaar J; Nicoloro SM; Czech MP
J Lipid Res; 2013 Oct; 54(10):2697-707. PubMed ID: 23924694
[TBL] [Abstract][Full Text] [Related]
12. Docosahexaenoic acid inhibits proteolytic processing of sterol regulatory element-binding protein-1c (SREBP-1c) via activation of AMP-activated kinase.
Deng X; Dong Q; Bridges D; Raghow R; Park EA; Elam MB
Biochim Biophys Acta; 2015 Dec; 1851(12):1521-9. PubMed ID: 26327595
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability.
Pajvani UB; Qiang L; Kangsamaksin T; Kitajewski J; Ginsberg HN; Accili D
Nat Med; 2013 Aug; 19(8):1054-60. PubMed ID: 23832089
[TBL] [Abstract][Full Text] [Related]
14. Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c.
Wan M; Leavens KF; Saleh D; Easton RM; Guertin DA; Peterson TR; Kaestner KH; Sabatini DM; Birnbaum MJ
Cell Metab; 2011 Oct; 14(4):516-27. PubMed ID: 21982711
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
[TBL] [Abstract][Full Text] [Related]
16. Fisetin regulates obesity by targeting mTORC1 signaling.
Jung CH; Kim H; Ahn J; Jeon TI; Lee DH; Ha TY
J Nutr Biochem; 2013 Aug; 24(8):1547-54. PubMed ID: 23517912
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis.
Zhang M; Chi X; Qu N; Wang C
Biochem Biophys Res Commun; 2018 Apr; 499(1):66-70. PubMed ID: 29555473
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the SREBP transcription factors by mTORC1.
Lewis CA; Griffiths B; Santos CR; Pende M; Schulze A
Biochem Soc Trans; 2011 Apr; 39(2):495-9. PubMed ID: 21428927
[TBL] [Abstract][Full Text] [Related]
19. mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis.
Laplante M; Sabatini DM
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3281-2. PubMed ID: 20167806
[No Abstract] [Full Text] [Related]
20. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis.
Yi J; Zhu J; Wu J; Thompson CB; Jiang X
Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31189-31197. PubMed ID: 33229547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
